EHR/EMR

Global Med Technologies Inc. Recieves FDA Clearance for ElDorado Donor(TM)

Global Med Technologies Inc., an international e-Health, medical information technology company, announced that the U.S. Food and Drug Administration has granted 510(k) clearance for ElDorado Donor(TM) a new blood management product produced by its Wyndgate Technologies(R) division (“Wyndgate”), paving the way for the Company to proceed marketing the product in the United States. The ElDorado Donor release is the Company’s next generation software and is intended as a comprehensive blood management software application created to provide for the information system needs of blood bank and donor centers. The software is designed to manage, automate and control activities associated with donors, donor collections, testing, manufacturing, inventory, and distribution. ElDorado Donor was developed with scalability in mind and is designed to manage the system needs of diverse facilities, from small hospital blood banks to community blood centers, to regional and national centers. The blood management software was designed with guidance from Wyndgate’s Technology Work Group (“TWG”), comprised of leading industry representatives from around the world. Throughout the ElDorado Donor development process, the TWG contributions assisted the Company in delivering a feature-rich and user-friendly solution.

Eletsonline News

Latest News

To Top